Low omega-6 vs. low omega-6 plus high omega-3 dietary intervention for Chronic Daily Headache: Protocol for a randomized clinical trial Public Deposited

Downloadable Content

Download PDF
Creator
  • Lynch, Chanee
    • Affiliation: School of Medicine, Department of Physical Medicine and Rehabilitation
    • Other Affiliation: Program on Integrative Medicine
  • Faurot, Keturah R
    • Affiliation: School of Medicine, Department of Physical Medicine and Rehabilitation
    • Other Affiliation: Program on Integrative Medicine
  • Imam, Syed
    • Affiliation: School of Medicine, Department of Physical Medicine and Rehabilitation
    • Other Affiliation: Program on Integrative Medicine
  • Suchindran, Chirayath
    • Affiliation: Gillings School of Global Public Health, Department of Biostatistics
  • Smith, Sunyata
    • Affiliation: School of Medicine, Department of Physical Medicine and Rehabilitation
    • Other Affiliation: Program on Integrative Medicine
  • Coble, Rebecca S
    • Affiliation: School of Medicine, Department of Physical Medicine and Rehabilitation
    • Other Affiliation: Program on Integrative Medicine
  • Ramsden, Christopher E
    • Affiliation: School of Medicine, Department of Physical Medicine and Rehabilitation
    • Other Affiliation: Section on Nutritional Neurosciences, Laboratory of Membrane Biochemistry and Biophysics, NIAAA, NIH, Bethesda, MD, USAProgram on Integrative Medicine
  • Gaylord, Susan A
    • Affiliation: School of Medicine, Department of Physical Medicine and Rehabilitation
    • Other Affiliation: Program on Integrative Medicine
  • Mann, J Douglas
    • Affiliation: School of Medicine, Department of Neurology
Abstract
  • Abstract Background Targeted analgesic dietary interventions are a promising strategy for alleviating pain and improving quality of life in patients with persistent pain syndromes, such as chronic daily headache (CDH). High intakes of the omega-6 (n-6) polyunsaturated fatty acids (PUFAs), linoleic acid (LA) and arachidonic acid (AA) may promote physical pain by increasing the abundance, and subsequent metabolism, of LA and AA in immune and nervous system tissues. Here we describe methodology for an ongoing randomized clinical trial comparing the metabolic and clinical effects of a low n-6, average n-3 PUFA diet, to the effects of a low n-6 plus high n-3 PUFA diet, in patients with CDH. Our primary aim is to determine if: A) both diets reduce n-6 PUFAs in plasma and erythrocyte lipid pools, compared to baseline; and B) the low n-6 plus high n-3 diet produces a greater decline in n-6 PUFAs, compared to the low n-6 diet alone. Secondary clinical outcomes include headache-specific quality-of-life, and headache frequency and intensity. Methods Adults meeting the International Classification of Headache Disorders criteria for CDH are included. After a 6-week baseline phase, participants are randomized to a low n-6 diet, or a low n-6 plus high n-3 diet, for 12 weeks. Foods meeting nutrient intake targets are provided for 2 meals and 2 snacks per day. A research dietitian provides intensive dietary counseling at 2-week intervals. Web-based intervention materials complement dietitian advice. Blood and clinical outcome data are collected every 4 weeks. Results Subject recruitment and retention has been excellent; 35 of 40 randomized participants completed the 12-week intervention. Preliminary blinded analysis of composite data from the first 20 participants found significant reductions in erythrocyte n-6 LA, AA and %n-6 in HUFA, and increases in n-3 EPA, DHA and the omega-3 index, indicating adherence. Trial Registration ClinicalTrials.gov (NCT01157208)
Date of publication
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
Rights holder
  • Christopher E Ramsden et al.; licensee BioMed Central Ltd.
License
Journal title
  • Trials
Journal volume
  • 12
Journal issue
  • 1
Page start
  • 97
Language
  • English
Is the article or chapter peer-reviewed?
  • Yes
ISSN
  • 1745-6215
Bibliographic citation
  • Trials. 2011 Apr 15;12(1):97
Access
  • Open Access
Publisher
  • BioMed Central Ltd
Parents:

This work has no parents.

Items